Related Experiment Video
Updated: Jan 21, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
Raddeanin A promotes apoptosis and ameliorates 5-fluorouracil resistance in cholangiocarcinoma cells
Shuang-Shuang Guo1, Ying Wang2, Qing-Xia Fan3
1Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China.
Background:
Bile duct cancer is characterized by fast metastasis and invasion and has been regarded as one of the most aggressive tumors due to the absence of effective diagnosis at an early stage. Therefore, it is in the urgent demand to explore novel diagnostic approaches and therapeutic strategies for bile duct cancer to improve patient survival. Raddeanin A (RA) is extracted from the anemone raddeana regel and has been demonstrated to play antitumor roles in various cancers.
Aim:
To investigate the effects of RA treatment on bile duct cancer cells.
Methods:
In this study, four cholangiocarcinoma cell lines (RBE, LIPF155C, LIPF178C, and LICCF) treated with RA were used to test the cell viability. The RA-associated cell functional analysis, 5-fluorouracil (5-Fu) effectiveness as well as cell cycle- and apoptosis-related protein expression were investigated.
Results:
RA reduced cell viability in a dose-dependent pattern in four cell lines, and the migration and colony formation abilities were also impaired by RA in RBE and LIPF155C cell lines. RA sensitized cell lines to 5-Fu treatment and enhanced the effects of 5-Fu in cholangiocarcinoma. Also, RA decreased protein expression of Wee1, while the combinational effect of RA and 5-Fu decreased protein expressions of cyclooxygenase-2, B cell lymphoma 2, and Wee1 but increased protein levels of Bax, cyclin D1, and cyclin E.
Conclusion:
Taken together, the results suggest that RA acts as an anti-cancer agent and enhancer of 5-Fu in bile duct cancer cells via regulating multiple cell cycle and apoptosis-related proteins. This finding provides novel clues to exploring a novel antitumor drug for bile duct cancer.
Insights
Raddeanin A (RA) shows anti-cancer effects against bile duct cancer by reducing cell viability and enhancing chemotherapy. RA also modulates key proteins involved in cell cycle and apoptosis.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Bile duct cancer (cholangiocarcinoma) is aggressive with poor early diagnosis.
- Novel therapeutic strategies are urgently needed to improve patient survival.
- Raddeanin A (RA), from *Anemone raddeana regel*, exhibits known antitumor properties.
Purpose of the Study:
- To evaluate the anti-cancer effects of Raddeanin A (RA) on bile duct cancer cells.
- To investigate RA's impact on cell viability, migration, and colony formation.
- To assess RA's potential to enhance chemotherapy with 5-fluorouracil (5-Fu).
Main Methods:
- Treatment of four cholangiocarcinoma cell lines (RBE, LIPF155C, LIPF178C, LICCF) with RA.
- Assessment of cell viability, migration, and colony formation.
- Analysis of cell cycle and apoptosis-related protein expression, including Wee1, COX-2, Bcl-2, Bax, cyclin D1, and cyclin E.
Main Results:
- RA reduced cell viability in a dose-dependent manner across all tested cell lines.
- RA impaired migration and colony formation in RBE and LIPF155C cell lines.
- RA sensitized cholangiocarcinoma cells to 5-Fu, enhancing its efficacy. RA and 5-Fu combination altered expression of multiple cell cycle and apoptosis proteins.
Conclusions:
- Raddeanin A demonstrates anti-cancer activity and acts as a 5-Fu sensitizer in bile duct cancer.
- RA modulates cell cycle and apoptosis pathways by regulating specific protein expressions.
- These findings suggest RA as a potential novel therapeutic agent for bile duct cancer.
Related Concept Videos
Apoptosis
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
5-Number Summary
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
Resistivity
Resistance

